Peter Wirth's Net Worth
$33.7 Million
Who is Peter Wirth?
Peter Wirth has an estimated net worth of $33.7 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Zai Lab Ltd, Forma Therapeutics Holdings, Inc., Syros Pharmaceuticals, Inc., SYNAGEVA BIOPHARMA CORP, and EPIX Pharmaceuticals, Inc..
SEC CIK
Peter Wirth's CIK is 0001021041
Past Insider Trading and Trends
2021 was Peter Wirth's most active year for acquiring shares with 6 total transactions. Peter Wirth's most active month to acquire stocks was the month of May. 2011 was Peter Wirth's most active year for disposing of shares, totalling 17 transactions. Peter Wirth's most active month to dispose stocks was the month of March. 2009 saw Peter Wirth paying a total of $6,835,379.20 for 289,180 shares, this is the most they've acquired in one year. In 2009 Peter Wirth cashed out on 464,360 shares for a total of $15,439,970.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENZYME CORP No price found
Exec VP,Legal & Corporate Dev.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.81K |
$74.00 | -$3,334,292.00 |
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +121.57% | 8.34K |
$45.62 | -$304,057.30 | 15.19K |
May 24 - May 25
| |||
Form 4
|
—
|
0
|
$38.50 | -$1,157,666.16 | 6.86K |
Scheduled
|
May 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
$47.97 | -$8,604,590.80 | 6.07K |
Scheduled
|
Jan 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| -100.00% | -231.00 |
$74.11 | -$17,119.41 |
0
|
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
$38.07 | -$2,312,796.64 | 6.35K |
May 9
| |||
Form 4
|
—
|
0
|
$38.67 | -$2,541,491.10 | 6.35K |
Scheduled
|
May 5
| ||
Form 4
| -17.69% | -1.46K |
$56.00 | -$81,928.00 | 6.8K |
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
$35.02 | -$2,102,000.00 | 7.31K |
Scheduled
|
Jan 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zai Lab Ltd (ZLAB) Snapshot price: $19.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.88% | 21.25K |
—
|
—
| 382.92K |
Jun 18
| |||
Form 4
| +5.51% | 18.9K |
$26.45 | $499,984.35 | 361.67K |
Jun 29
| |||
Form 4/A
|
∞
| 4K |
$71.36 | $285,440.00 | 4K |
Dec 8
| |||
Form 4
| -2.24% | -7.85K |
$35.35 | -$277,565.24 | 342.76K |
Dec 8
| |||
Form 4
| +2.26% | 7.76K |
—
|
—
| 350.62K |
Jan 3
| |||
Form 4
| +1.18% | 4K |
$71.36 | $285,440.00 | 342.85K |
Dec 8
| |||
Form 4
| +1.15% | 3.85K |
—
|
—
| 338.85K |
Jan 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Forma Therapeutics Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -134.91K |
—
|
—
|
0
|
Oct 14
| |||
Form 4
| +3.45% | 4.5K |
—
|
—
| 134.91K |
Jun 8
| |||
Form 4
| +2.15% | 2.75K |
—
|
—
| 130.41K |
Jun 17
| |||
Form 4
| -10.61% | -15.15K |
—
|
—
| 127.67K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $7.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.33% | 4K |
—
|
—
| 16K |
Jun 5
| |||
Form 4
| +50.00% | 4K |
—
|
—
| 12K |
Jun 1
| |||
Form 4
|
∞
| 8K |
—
|
—
| 8K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNAGEVA BIOPHARMA CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||